Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Look Over Your Shoulder, Roche: Abbott’s Coming Up Behind

This article was originally published in Clinica

Executive Summary

Abbott Labs’ proposed $5.8bn acquisition of Alere will give its IVD sales a significant boost and propel the company up the ranks to become the sector’s No. 2, behind Roche.


Related Content

Despite Legal Dispute, Abbott Set To Buy Alere for $5.3bn
Alere Hit With Another Federal Subpoena, Casting More Doubt On Abbott Deal





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts